Taylor Hoyt, | |
13 Corporate Plaza Dr Ste 100, Newport Beach, CA 92660-7964 | |
(949) 919-0428 | |
Not Available |
Full Name | Taylor Hoyt |
---|---|
Gender | Male |
Speciality | Psychologist |
Location | 13 Corporate Plaza Dr Ste 100, Newport Beach, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134816580 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Taylor Hoyt, 13 Corporate Plaza Dr Ste 100, Newport Beach, CA 92660-7964 Ph: (949) 919-0428 | Taylor Hoyt, 13 Corporate Plaza Dr Ste 100, Newport Beach, CA 92660-7964 Ph: (949) 919-0428 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions, today announced a strategic partnership with the American Society for Gastrointestinal Endoscopy (ASGE) that will offer the more than 11,000 members of this international organization a unique service designed to ease the process of selecting and preparing for an electronic health record (EHR) system. ASGE promotes the highest standards for endoscopic training and practice, fosters endoscopic research and is the foremost resource for endoscopic education.
Indonesia's death toll from bird flu has now reached 51 with the death last week of a young child from South Jakarta.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
› Verified 3 days ago
Margaret Mary Decker, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1600 Dove St, Suite 140, Newport Beach, CA 92660 Phone: 949-922-1529 Fax: 949-809-5779 | |
Dr. Paul T Depompo, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4060 Campus Dr, Suite 120, Newport Beach, CA 92660 Phone: 949-300-1952 Fax: 949-313-1723 | |
Dr. Jacqueline A Josephson, PSY.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1400 Quail St Ste 136, Newport Beach, CA 92660 Phone: 510-686-3306 | |
Ghada Al-seilawi, EDUCATIONAL PSYCHOLO Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Dove St Ste 270, Newport Beach, CA 92660 Phone: 949-432-4815 | |
Dr. Vance B Becker, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1451 Quail St, Ste 102, Newport Beach, CA 92660 Phone: 949-757-1113 Fax: 949-757-1114 | |
Ms. Dana Emerson Basu, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 2549 Eastbluff Dr # 134, Newport Beach, CA 92660 Phone: 608-575-2111 Fax: 949-220-7004 | |
Dr. Carey Sherilyn Incledon, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Dove St Ste 190, Newport Beach, CA 92660 Phone: 949-630-0630 Fax: 949-688-5577 |